Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-02-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a formal public statement nominating an individual as an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with various regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report summaries. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is about 5,042 characters, which is sufficient for a detailed nomination statement rather than a brief announcement or certification.
2019-02-27 Chinese
独立董事候选人声明（吴剑）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes multiple attestations about qualifications, independence, and absence of conflicts of interest. There is no financial data, no discussion of company financial performance, no voting results, no management changes, no earnings information, and no mention of report publication. The content is focused on governance and regulatory compliance related to board membership. This type of document fits best under Board/Management Information (MANG), as it relates to board member candidacy and declarations.
2019-02-27 Chinese
独立董事2018年度述职报告（徐永光）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2018 Annual Report" and contains detailed descriptions of the independent director's activities, attendance at board and shareholder meetings, opinions on company matters, investigations, committee roles, and efforts to protect investor rights during the 2018 fiscal year. It is a narrative report on the independent director's duties and observations rather than a financial report or regulatory filing. The content focuses on governance and oversight rather than financial results or audit opinions alone. This aligns with a Management Report or similar governance-related disclosure. However, since it is specifically an independent director's annual report on their duties and opinions, it fits best under Board/Management Information (MANG), which covers announcements related to board members and senior management activities and reports. The document length is under 5,000 characters, but it is a substantive report, not merely an announcement of a report publication, so it is not RPA. It is not a certification or attestation document, so not RNS. Therefore, the best classification is MANG with high confidence.
2019-02-27 Chinese
关于公司募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's raised funds (募集资金) including the amount raised, usage, storage, and compliance with regulatory requirements. It references approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange guidelines, and provides detailed tables on fund allocation, usage, and project progress. The document is titled as a "专项报告" (special report) on the storage and actual use of raised funds for the year 2018. This type of report is typically a capital/financing update related to fundraising activities and the use of proceeds from a non-public stock issuance. It is not an annual report, earnings release, or audit report, nor is it a simple announcement or certification. The content focuses on the management and use of capital raised, fitting the Capital/Financing Update category (CAP). The document length (6440 characters) and detailed financial data support this classification with high confidence.
2019-02-27 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of the supervisory board members (监事会换届选举) of 嘉事堂药业股份有限公司. It details the nomination and election process of the new supervisory board members, their resumes, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on management/board changes, specifically the supervisory board election. Therefore, this fits the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is not a report publication announcement; it is a substantive announcement about board changes.
2019-02-27 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of 嘉事堂药业股份有限公司 regarding a change in accounting policies. It details the reasons for the change, the specific accounting standards affected, the impact on financial statement line items, and includes approvals from the board, supervisory board, and independent directors. The document does not contain actual financial statements or comprehensive financial data but rather explains the policy change and its implications. The length is 4074 characters, which is relatively short and consistent with an announcement rather than a full report. This fits best with a Regulatory Filings (RNS) classification, as it is a regulatory announcement about accounting policy changes without full financial statements or detailed financial analysis.
2019-02-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.